Chr. Hansen Expands Production Facilities For Probiotics

Drinking yoghurt_highweb.jpg

19 Feb 2013 --- A new freeze-drying plant for probiotic cultures for dietary supplements is in the making in Denmark. A new market analysis predicts the global probiotics market to surge by 6.8% a year until 2018, driven by Asia-Pacific with Europe as another dominant market in spite of current health claim law issues (source: The Global Industry Analysis).

--- In sales terms this corresponds to USD 27.9 billion in 2011, forecast to reach US$44.9 bn in 2018.

The increasing culture sales, both in terms of probiotics and food cultures, puts pressure on Chr. Hansen’s production facilities and in order to sustain the growing customer demand the global bioscience company is investing in expanding its capacity.

“Over the past years we have worked to turn our production facility at Roskilde south of Copenhagen into a dedicated production site for human health products, both to live up to pharma GMPs and to free capacity at our food culture production site in Copenhagen,” says Henrik Dalboege, Executive Vice President, Human Health & Nutrition Division, Chr. Hansen.

“We started the construction work on the new freeze-drying plant just before Christmas and I am very pleased to see this project progressing as planned. It is an important element in sustaining the current and future growth of the Human Health & Nutrition Division and its contribution to the entire group”.

The lay-out of the new plant ensures that visitors can observe and inspect the main operations and equipment during the production process. Customers will encounter a state-of-the-art production facility with a high level of hygienic design of both clean rooms and production equipment.

Furthermore the new plant is designed to improve working conditions and with the use of 1:1 models of different work stations it has been designed and pre-approved according to occupational health and safety standards before the construction work was started. Additional benefits are new modern offices and a new maintenance workshop.

Once finished in spring 2014 it will be the world’s largest freeze-drying plant for pharmaceutical grade probiotic cultures.

To contact our editorial team please email us at editorial@cnsmedia.com

Chr. Hansen

Collapse

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Related Articles

Nutrition & Health News

Bone and joint health: Consumer demands and promising ingredients

19 Apr 2018 --- Mobility, which incorporates bone and joint health, is becoming a key concern for a range of demographics. NutritionInsight spoke with a number of key suppliers in the bone and joint health space about the key ingredients to look out for, as well as some key consumer demands driving innovation in this space.

Nutrition & Health News

Plant-based possibilities: Report details novel sugar replacements for beverages

19 Apr 2018 --- PreScouter, a Chicago based technology scouting company, details novel replacements for sugars in a new analysis, that are from natural sources, safe, technologically viable and environmentally stable, for use in beverages. The company hopes that the report answers consumer calls for sweeteners that are both natural and healthy, in light of diabetes and obesity epidemics, and that it may aid informing beverage providers on how to best respond to calls for lowering sugar levels in drinks.

Nutrition & Health News

New study sheds light on non-celiac gluten avoidance

18 Apr 2018 --- People who avoid gluten in their diets, often avoid other food types – such as dairy and eggs – and are more likely to experience frequent adverse physiological symptoms after food consumption. The research sought to uncover why the popularity of gluten-free diets has risen so much amongst those who do not have medical gluten sensitivities.

Nutrition & Health News

Probiotic peanut allergy treatment: Chr. Hansen enters new partnership

18 Apr 2018 --- Probiotic strain, LGG, can potentially play a part in peanut allergy treatment. Prota Therapeutics, developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen, Danish food ingredients producer, to assess LGG in a clinical trial to develop a treatment for the allergy. Chr. Hansen tells NutritionInsight that the partnership is in effect as from today, and strengthens the position of Chr. Hansen in a market expected to grow to €10billion by 2025.

Nutrition & Health News

Anlit launches “fun and tasty” omega 3 chew for pregnant women

18 Apr 2018 --- Producers of high-quality children’s dietary supplements, Anlit, have launched "tasty", high-DHA omega 3 chewable supplements for pregnant and breastfeeding women. 

More Articles
URL : http://www.nutritioninsight.com:80/news/Chr-Hansen-Expands-Production-Facilities-For-Probiotics.html